Low-dose aspirin does not reduce adverse heart, lung outcomes in stable COVID patients: study
By
Alicia Lasek
Oct 19, 2021
Contrary to some clinical observations, aspirin and apixaban (Eliquis) do not reduce the rate of major adverse cardiovascular or pulmonary outcomes in stable outpatients with symptomatic COVID-19, researchers...
Anticoagulants advised following certain COVID-19 acute-care stays
By
Alicia Lasek
Nov 29, 2021
Clinicians disagree about the need for continued anticoagulation therapy to reduce blood clot risks following COVID-19 hospitalization. A new study suggests that patients with certain medical histories...